Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I.

Radiology. 2012 Nov;265(2):468-77. doi: 10.1148/radiol.12112087. Epub 2012 Sep 25.

2.

Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.

Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A.

Radiology. 2012 Apr;263(1):160-8. doi: 10.1148/radiol.12111205. Epub 2012 Feb 17.

PMID:
22344404
3.

Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.

Murray CA, Quon M, McInnes MD, van der Pol CB, Hakim SW, Flood TA, Schieda N.

AJR Am J Roentgenol. 2016 Sep;207(3):585-91. doi: 10.2214/AJR.16.16062. Epub 2016 Jun 8.

PMID:
27275530
4.

Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.

Jhaveri KS, Elmi A, Hosseini-Nik H, Hedgire S, Evans A, Jewett M, Harisinghani M.

AJR Am J Roentgenol. 2015 Jul;205(1):W79-86. doi: 10.2214/AJR.14.13245.

PMID:
26102422
5.

Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.

Kim JK, Kim SH, Jang YJ, Ahn H, Kim CS, Park H, Lee JW, Kim S, Cho KS.

Radiology. 2006 Apr;239(1):174-80. Epub 2006 Feb 28.

PMID:
16507752
6.

Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors.

Chung MS, Choi HJ, Kim MH, Cho KS.

AJR Am J Roentgenol. 2014 Apr;202(4):765-71. doi: 10.2214/AJR.13.11058.

PMID:
24660704
7.

Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.

Park JJ, Kim CK.

AJR Am J Roentgenol. 2017 Jan;208(1):124-130. doi: 10.2214/AJR.16.16102. Epub 2016 Nov 8.

PMID:
27824487
8.

Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma.

Chaudhry HS, Davenport MS, Nieman CM, Ho LM, Neville AM.

AJR Am J Roentgenol. 2012 Feb;198(2):377-83. doi: 10.2214/AJR.11.6887.

PMID:
22268181
9.

Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.

Jeong CJ, Park BK, Park JJ, Kim CK.

AJR Am J Roentgenol. 2016 Feb;206(2):340-7. doi: 10.2214/AJR.15.15086.

PMID:
26797361
10.

Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.

Verma SK, Mitchell DG, Yang R, Roth CG, O'Kane P, Verma M, Parker L.

Radiology. 2010 May;255(2):501-7. doi: 10.1148/radiol.09091109. Epub 2010 Feb 16.

PMID:
20160001
11.

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I.

Radiology. 2009 Mar;250(3):793-802. doi: 10.1148/radiol.2503080995.

PMID:
19244046
12.

Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.

Choi HJ, Kim JK, Ahn H, Kim CS, Kim MH, Cho KS.

Acta Radiol. 2011 Apr 1;52(3):349-53. doi: 10.1258/ar.2010.090491. Epub 2011 Mar 3.

PMID:
21498374
13.

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, Yacoub M, Bouzgarrou M, Ravaud A, Grenier N.

Eur Radiol. 2014 May;24(5):1068-80. doi: 10.1007/s00330-014-3107-z. Epub 2014 Feb 21.

PMID:
24557052
14.

MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis.

Schieda N, Dilauro M, Moosavi B, Hodgdon T, Cron GO, McInnes MD, Flood TA.

Eur Radiol. 2016 Jul;26(7):2242-51. doi: 10.1007/s00330-015-4039-y. Epub 2015 Oct 20.

PMID:
26486936
15.

Double-echo gradient chemical shift MR imaging fails to differentiate minimal fat renal angiomyolipomas from other homogeneous solid renal tumors.

Ferré R, Cornelis F, Verkarre V, Eiss D, Correas JM, Grenier N, Hélénon O.

Eur J Radiol. 2015 Mar;84(3):360-365. doi: 10.1016/j.ejrad.2014.11.040. Epub 2014 Dec 15.

PMID:
25547327
16.

Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.

Kim JK, Park SY, Shon JH, Cho KS.

Radiology. 2004 Mar;230(3):677-84.

PMID:
14990834
17.

Homogeneous T1 Hyperintense Renal Lesions with Smooth Borders: Is Contrast-enhanced MR Imaging Needed?

Davarpanah AH, Spektor M, Mathur M, Israel GM.

Radiology. 2016 Jul;280(1):128-36. doi: 10.1148/radiol.16151240. Epub 2016 Feb 25.

PMID:
26919441
18.

Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma.

Rosenkrantz AB, Raj S, Babb JS, Chandarana H.

Eur J Radiol. 2012 Jan;81(1):47-51. doi: 10.1016/j.ejrad.2010.11.012. Epub 2010 Dec 3.

PMID:
21126839
19.

Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.

Oliva MR, Glickman JN, Zou KH, Teo SY, Mortelé KJ, Rocha MS, Silverman SG.

AJR Am J Roentgenol. 2009 Jun;192(6):1524-30. doi: 10.2214/AJR.08.1727.

PMID:
19457814
20.

In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.

Childs DD, Clingan MJ, Zagoria RJ, Sirintrapun J, Tangtiang K, Anderson A, Leyendecker JR.

AJR Am J Roentgenol. 2014 Oct;203(4):W421-8. doi: 10.2214/AJR.13.11113.

PMID:
25247971

Supplemental Content

Support Center